[1] |
CHEN Manxin, ZHANG Bingyu, DAI Min.
Clinical efficacy of intracoronally targeted recombinant human urokinase combined with percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) with high thrombus burden
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 544-549.
|
[2] |
PANG Shengfeng, ZHANG Jing, WU Ningning, LI Ru, CAO Jun, HE Shenghu.
Efficacy of antiplatelet therapy with ticagrelor monotherapy after short-term double antibody therapy in patients with acute coronary syndrome after PCI
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1004-1009.
|
[3] |
ZENG Xiaofan, XU Yiqi, LIU Shu, WU Qian, LI Zibao, HE Junjun, JIN Yuelong, ZHAO Yongli, HE Chunling, GAO Jialin.
Retrospectively analysis of the effect of low-dose aspirin on primary prevention of non-fatal myocardial infarction and cerebral infarction in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 665-671.
|
[4] |
CAI Zichun, JIANG Yuanzhen, ZHANG Chunsheng, LI Jiming.
Research progress and application prospects of circRNA in cardiovascular diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 397-404.
|
[5] |
LU Xiya, LI Yuxing, LI Wenzhi, PENG Yuanyuan, HU Yi, WAN Li, CHEN Bilian.
Analysis of prescribing of antiplatelet drug in patients with coronary heart disease in department of geriatrics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1285-1291.
|
[6] |
GUO Shengjie, GUAN Xirui, CAO Wenli, LIANG Sicheng, QI Xiaoyi, GE Guangbo, LV Muhan.
Research progress on bile acid metabolism mediated by uridine diphosphate glucuronic acid transferase and its endogenous and exogenous influencing factors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 102-107.
|
[7] |
DENG Yifan, HE Shenghu, WANG Daxin, DAI Chengye, XU Xiaoting, ZHANG Jing.
Clinical study of effect of ezetimibe combined with statins on residual lipoprotein cholesterol and MACE events in patients undergoing emergency intervention with acute coronary syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1048-1052.
|
[8] |
WANG Tiantian, ZHANG Rongrong, WU Changfan.
Current research of drug interventions in the occurrence and development of myopia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 808-813.
|
[9] |
LI Lihua, ZHANG Shengpeng, QIN Jiaxu, NIAN Sihui.
Protective effects of the extract from Toona sinensis seeds on gastric mucosa injury in experimental mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 546-551.
|
[10] |
WANG Fengling, MENG Xiangyun, CHEN Zhengxu, CAO Rongjuan, HE Zhengmin, YE Xi, WANG Cong, LI Qi.
Analysis on genetic polymorphism of SLCO1B1 and ApoE in patients with cardiovascular diseases of Han nationality in Anhui area and its clinical significance for individualized use of statins
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 40-48.
|
[11] |
YANG Ming, DONG Xiaowen, HONG Huashan.
Statins for primary prevention of atherosclerotic cardiovascular disease in people 75 years of age and older
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1074-1080.
|
[12] |
YAN Yu, LIU Kang, LIAN Wenwen, ZHANG Zhen, HE Jun.
Research progress on roles of gut microbiota in cardiovascular disease and treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 829-834.
|
[13] |
ZHANG Haowen, ZHU Yejin, WU Xiang, CHEN Hanyu, SONG Yulei, BIAN Yaoyao, HAO Haiping, CHEN Xiaohu.
Study on high on-aspirin platelet reactivity in diabetic mice based on metabonomics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 246-256.
|
[14] |
XIANG Yuxia, ZENG Chan, HUANG Zhijun, WANG Xiaomin, ZHANG Zeyu, YANG Guoping.
Analysis of clinical trial registration information of COVID-19 in China
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 135-140.
|
[15] |
HU Defeng, WANG Yihu, LONG Xiaoyu, WANG Guangshui.
Intervention effect of modified Ganmaidazao Tang combined with cognitive behavioral intervention on ultra-high risk for developing psychosis and the effects on cognitive function, quality of life and serum levels of 5-HT, MT and TSH
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 546-553.
|